Scientific research and product development in the United States to address injuries from a radiation public health emergency
Open Access
- 24 July 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 62 (5) , 752-763
Abstract
The USA has experienced one large-scale nuclear incident in its history. Lessons learned during the Three-Mile Island nuclear accident provided government planners with insight into property damage resulting from a low-level release of radiation, and an awareness concerning how to prepare for future occurrences. However, if there is an incident resulting from detonation of an improvised nuclear device or state-sponsored device/weapon, resulting casualties and the need for medical treatment could overwhelm the nation’s public health system. After the Cold War ended, government investments in radiation preparedness declined; however, the attacks on 9/11 led to re-establishment of research programs to plan for the possibility of a nuclear incident. Funding began in earnest in 2004, to address unmet research needs for radiation biomarkers, devices and products to triage and treat potentially large numbers of injured civilians. There are many biodosimetry approaches and medical countermeasures (MCMs) under study and in advanced development, including those to address radiation-induced injuries to organ systems including bone marrow, the gastrointestinal (GI) tract, lungs, skin, vasculature and kidneys. Biomarkers of interest in determining level of radiation exposure and susceptibility of injury include cytogenetic changes, ‘omics’ technologies and other approaches. Four drugs have been approved by the US Food and Drug Administration (FDA) for the treatment of acute radiation syndrome (ARS), with other licensures being sought; however, there are still no cleared devices to identify radiation-exposed individuals in need of treatment. Although many breakthroughs have been made in the efforts to expand availability of medical products, there is still work to be done.Keywords
This publication has 96 references indexed in Scilit:
- Skin Inqjuries Reduce Survival and Modulate Corticosterone, C-Reactive Protein, Complement Component 3, IgM, and Prostaglandin E2after Whole-Body Reactor-Produced Mixed Field (n +-Photons) IrradiationOxidative Medicine and Cellular Longevity, 2013
- Wound trauma alters ionizing radiation dose assessmentCell & Bioscience, 2012
- Hematological Changes as Prognostic Indicators of Survival: Similarities Between Gottingen Minipigs, Humans, and Other Large Animal ModelsPLOS ONE, 2011
- Captopril and Losartan for Mitigation of Renal Injury Caused by Single-Dose Total-Body IrradiationRadiation Research, 2011
- The NIAID Radiation Countermeasures Program Business ModelBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2010
- BIOMIMETIC ACTINIDE CHELATORS: AN UPDATE ON THE PRECLINICAL DEVELOPMENT OF THE ORALLY ACTIVE HYDROXYPYRIDONATE DECORPORATION AGENTS 3,4,3-LI(1,2-HOPO) AND 5-LIO(ME-3,2-HOPO)Health Physics, 2010
- Animal Models for Medical Countermeasures to Radiation ExposureRadiation Research, 2010
- Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrusRadiation Oncology, 2010
- Delaying DLA-Haploidentical Hematopoietic Cell Transplantation after Total Body IrradiationTransplantation and Cellular Therapy, 2009
- Radiation accidentsAnnals of Emergency Medicine, 1986